 twelve-year comparison bjork-shiley mechan heart valv porcin bioprosthes background patient heart-valv replac mechan prosthesi lifelong anticoagul treatment porcin bioprosthesi absolut need anticoagul method random prospect trial durabl bjork-shiley mechan prosthesi spheric tilting-disk model incid valve-rel complic variabl hancock carpentier-edward porcin prosthes mitral valv patient aortic valv survivor mean year result trend improv actuari surviv year bjork-shiley prosthesi trend signific group bjork-shiley valv group porcin valv mean SE percent signific differ actuari incid reoper year year patient porcin prosthesi undergon reoper percent analysi death reoper end point actuari assess surviv origin prosthesi intact patient bjork-shiley shiley prosthes surviv percent year hospit blood transfus frequent patient bjork-shiley prosthes percent year signific differ year actuari occurr embol bjork-shiley porcin percent endocard vs percent conclus surviv intact valv patient bjork-shiley spheric tilting-disk prosthesi patient porcin bioprosthes use bjork-shiley valv attend risk need anticoagul treatment